Drugs, Driving and Traffic Safety

Driver health and traffic safety: an overview.- Worldwide trends in alcohol and drug impaired driving.- Drugs, driving, and models to measure driving impairment.- Measurement and methods to determine driving ability.- Simulator studies of drug-induced driving impairment.- The on-the-road driving test.- Epidemiology and traffic safety: culpability studies.- Case-control studies.- Prescribing and dispensing guidelines for medicinal drugs affecting driving performance.- The relationship between drug use and traffic accident severity.- Pharmacokinetics and pharmacodynamics of drugs abused in driving.- The role of driver sleepiness in car crashes: a review of the epidemiological evidence.- Sleepiness, countermeasures and the risk of motor vehicle accidents.- Insomnia, hypnotic drugs and traffic safety.- Drugs, driving and traffic safety in sleep apnea.- Drugs, driving and traffic safety in shift workers.- Effects of anxiolytics on driving.- Antidepressants and traffic safety.- Attention deficit/hyperactivity disorder (ADHD) and driving safety.- Drugs, driving and traffic safety in Parkinson's disease.- Drugs, driving and traffic safety in multiple sclerosis.- Drugs, driving and traffic safety in acute and chronic pain.- Drugs, driving and traffic safety in allergic rhinitis.- Drugs, driving and traffic safety in diabetes mellitus.- Changes in and predictors of driving after drug use and involvement in traffic crashes because of drugs, 1992-2005.- Reducing illegal blood alcohol limits for driving: effects on traffic safety.- Interventions to reduce impaired driving and traffic injury.- The alcohol ignition interlock and other technologies for the prediction and control of impaired drivers.- Dose related risk of motor vehicle crashes after cannabis use: an update.-Ecstasy, driving and traffic safety.- Appendix I ICADTS Drug List 2007.- Appendix II International Council on Alcohol, Drugs and Traffic Safety. Guidelines on experimental studies undertaken to determine a medicinal drug's effect on driving or skills related to driving.

"This is a substantial volume with 59 contributors providing 30 chapters and 2 appendices. The various chapters cover the gamut of topics and issues related to drugs, driving and traffic safety and the editors are to be congratulated on recruiting an internationally diverse group of well-recognised authorities in the subject matter of the various fields of interest covered. 'Drugs and Driving' is arguably one of the broadest canvasses within Psychopharmacology but, by and large, these individual chapters do coalesce to give an integrated expert commentary. Basically there are three topic areas, though the book is in no way divided as such. The first contains contributions on aspects of health, epidemiology and traffic safety; the role of drugs and/or sleepiness as causal agents in traffic accidents; methods and measures for assessing car driving ability. The second area examines the pharmacokinetic/pharmacodynamic properties of drugs; the effects of alcohol, cannabis, Ecstasy, hypnotics, anxiolytics and antidepressants on measures of driving ability and the relationship between drugs, driving and traffic safety in shift-workers, Parkinson's disease, multiple sclerosis, attention-deficit hyperactivity disorder (ADHD), sleep apnoea, pain, allergic rhinitis and diabetes mellitus. Finally, there are papers discussing predictors of accidents and patterns of drug-involved traffic accidents and countermeasures and ways of reducing/preventing impaired drivers taking the wheel ... this excellent book will provide insight for those measuring, treating, regulating and researching the effects of psychoactive drugs on car driving ability and accident liability." Ian Hindmarch - Hum. Psychopharmacol Clin Exp 2010; 25: 191

"This is a substantial volume with 59 contributors providing 30 chapters and 2 appendices. The various chapters cover the gamut of topics and issues related to drugs, driving and traffic safety and the editors are to be congratulated on recruiting an internationally diverse group of well-recognised authorities in the subject matter of the various fields of interest covered.
‘Drugs and Driving’ is arguably one of the broadest canvasses within Psychopharmacology but, by and large, these individual chapters do coalesce to give an integrated expert commentary.
Basically there are three topic areas, though the book is in no way divided as such. The first contains contributions on aspects of health, epidemiology and traffic safety; the role of drugs and/or sleepiness as causal agents in traffic accidents; methods and measures for assessing car driving ability.
The second area examines the pharmacokinetic/pharmacodynamic properties of drugs; the effects of alcohol, cannabis, Ecstasy, hypnotics, anxiolytics and antidepressants on measures of driving ability and the relationship between drugs, driving and traffic safety in shift-workers,
Parkinson’s disease, multiple sclerosis, attention-deficit hyperactivity disorder (ADHD), sleep apnoea, pain, allergic rhinitis and diabetes mellitus.
Finally, there are papers discussing predictors of accidents and patterns of drug-involved traffic accidents and countermeasures and ways of reducing/preventing impaired drivers taking the wheel ...
this excellent book will provide insight for those measuring, treating, regulating and researching the effects of psychoactive drugs on car driving ability and accident liability." Ian Hindmarch - Hum. Psychopharmacol Clin Exp 2010; 25: 191